AUTOBIO DIAGNOSTIC (China) Profile

603
Analyze Filter   Check how we calculate scores
Equity ratings for AUTOBIO DIAGNOSTIC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 23, 2019 and ending today January 21, 2020. Click here to learn more.
AUTOBIO DIAGNOSTIC cannot be verified against its exchange. It appears AUTOBIO DIAGNOSTIC is not available for investing at the moment. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

AUTOBIO DIAGNOSTIC Profile

Legal NameAUTOBIO DIAGNOSTIC
Chairman of the BoardYongjun MiaoView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
AUTOBIO DIAGNOSTIC (603658) is traded on Shanghai Stock Exchange in China and employs 12 people. The company currently falls under 'Large-Cap' category with current market capitalization of 28.14 B.
Check AUTOBIO DIAGNOSTIC Probability Of Bankruptcy

AUTOBIO DIAGNOSTIC Against Markets

AUTOBIO DIAGNOSTIC cannot be verified against its exchange. It appears AUTOBIO DIAGNOSTIC is not available for investing at the moment. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

See also Trending Equities. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Company logos by clearbit